We seek to establish a core facility for the synthesis of combinatorial chemical libraries and for the screening of HIV protease inhibitors. The core facility will be equipped with an Argonaut TridentTM automated synthesizer and a Zymark AllegroTM high throughput screening workstation. The Trident automated synthesizer is a flexible instrument that can be operated in semi- and fully-automated modes allowing the synthesis of small and large libraries in parallel as well as in the split-and-pool methods. This synthesizer is an ideal instrument to carry out multistep solution and solid-phase reactions involving difficult chemistry over a wide range of reaction conditions. The Allegro high throughput screening workstation is a modular system that allows optimization and flexibility of assay conditions necessary to perform a variety of assays. The instrument is capable of fast and accurate liquid handling as well as a variety of assay readout options and can carry out hundreds of screening experiments per day. The goal of the core facility is to generate chemical diversity using well established combinatorial chemical synthesis methods and screen inhibitors of wild-type and mutants HIV proteases. Both in parallel and the split-and-pool synthesis approaches will be used. Peptidomimetic and non-peptidomimetic scaffolds will be used to generate chemical libraries. Natural and unnatural residues will be synthesized and linked via a variety of backbone structures during combinatorial chemical library synthesis. The high throughput screening component of the core facility will allow the development of new screening methods and identification of new ligands that can target specific structures and sequences of wild-type and mutant HIV proteases. The primary connection between the core facility and the program project will be with the Schiffer, Gilson, and Tidor groups. The goals of their proposed research rely on the synthesis of combinatorial chemical libraries and identification of HIV protease ligands. In addition, the Swanstrom group will impact the core facility through providing us with the knowledge of resistance mechanisms and toxicity studies on new inhibitors. The results of combinatorial chemical synthesis and screening approaches will allow the generation of rapid feedback to test the theoretical design criteria developed using computational methods.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
1P01GM066524-01
Application #
6553772
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Zhou, Hao; Li, Shangyang; Badger, John et al. (2015) Modulation of HIV protease flexibility by the T80N mutation. Proteins 83:1929-39
Lee, Sook-Kyung; Cheng, Nancy; Hull-Ryde, Emily et al. (2013) A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid. Biochemistry 52:4929-40
Shen, Yang; Altman, Michael D; Ali, Akbar et al. (2013) Testing the substrate-envelope hypothesis with designed pairs of compounds. ACS Chem Biol 8:2433-41
Silver, Nathaniel W; King, Bracken M; Nalam, Madhavi N L et al. (2013) Efficient Computation of Small-Molecule Configurational Binding Entropy and Free Energy Changes by Ensemble Enumeration. J Chem Theory Comput 9:5098-5115
Foulkes-Murzycki, Jennifer E; Rosi, Christina; Kurt Yilmaz, Nese et al. (2013) Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease. ACS Chem Biol 8:513-8
Schiffer, Celia (2013) Interview with Celia Schiffer. Future Med Chem 5:1193-7
Nalam, Madhavi N L; Ali, Akbar; Reddy, G S Kiran Kumar et al. (2013) Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance. Chem Biol 20:1116-24
Mittal, Seema; Bandaranayake, Rajinthna M; King, Nancy M et al. (2013) Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50. J Virol 87:4176-84
Parai, Maloy Kumar; Huggins, David J; Cao, Hong et al. (2012) Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance. J Med Chem 55:6328-41
Ishima, Rieko (2012) Recent developments in (15)N NMR relaxation studies that probe protein backbone dynamics. Top Curr Chem 326:99-122

Showing the most recent 10 out of 73 publications